|
|
||||||||
Ann Thorac Surg 2006;82:1016-1020
© 2006 The Society of Thoracic Surgeons
a Department of Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama
b Section of Thoracic Surgery at University of Alabama at Birmingham, Birmingham, Alabama
c Division of Cardiothoracic Surgery, Department of Surgery at the Birmingham Veterans Administration Hospital, Birmingham, Alabama
Accepted for publication March 29, 2006.
* Address correspondence to Dr Cerfolio, Division of Cardiothoracic Surgery, University of Alabama at Birmingham, 1900 University Blvd., THT 712, Birmingham, AL 35294 (Email: rcerfolio{at}uab.edu).
Presented at the Poster Session of the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30Feb 1, 2006.
BACKGROUND: Positron emission tomography (PET) is often used for an indeterminate pulmonary nodule.
METHODS: This is a prospective study on a consecutive series of patients who had an indeterminate pulmonary nodule that was 2.5 cm or less, underwent integrated positron emission tomography using fluorodeoxyglucose-PET/computed tomographic [FDG-PET/CT] scan with the maximum standardized uptake values (maxSUVs) reported, and who underwent complete resection.
RESULTS: There were 585 patients (401 men). A total of 496 patients had a malignant nodule and the median maxSUV was 8.5 (range, 0 to 36). Eighty-nine patients had a benign nodule and the median maxSUV was 4.9 (range, 0 to 28, p < 0.001). If the maxSUV was between 0 and 2.5 there was a 24% chance the nodule was malignant, if between 2.6 and 4.0 it was 80%, and if 4.1 or greater it was 96%. False negative FDG-PET/CT was from bronchoalveolar carcinoma in 11 patients, carcinoid in 4, and renal cell in 2. False positives included fungal infections in 16 patients. Nodal involvement, whether malignant or infectious, was more likely with a pulmonary mass that had a higher maxSUV (8.4 vs 3.8 for nonmalignant lesions, 9.8 vs 4.5 for malignant lesions).
CONCLUSIONS: Although integrated FDG-PET/CT is a valuable study for an indeterminate pulmonary nodule, one must be aware of causes of false positives and negatives. There is a 24% chance a suspicious nodule that has a maxSUV of 0 to 2.5 is cancer. The higher the maxSUV of the primary mass the more likely the nodes are to be involved with either malignancy or infection, and this may help direct nodal biopsy instead of pulmonary resection.
This article has been cited by other articles:
![]() |
B. Goudarzi, H. A. Jacene, and R. L. Wahl Diagnosis and Differentiation of Bronchioloalveolar Carcinoma from Adenocarcinoma with Bronchioloalveolar Components with Metabolic and Anatomic Characteristics Using PET/CT J. Nucl. Med., October 1, 2008; 49(10): 1585 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Donmez, E. Yekeler, V. Saeidi, A. Tunaci, M. Tunaci, and G. Acunas Dynamic Contrast Enhancement Patterns of Solitary Pulmonary Nodules on 3D Gradient-Recalled Echo MRI Am. J. Roentgenol., December 1, 2007; 189(6): 1380 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Mineo, V. Ambrogi, D. Mineo, and E. Pompeo Transxiphoid Hand-Assisted Videothoracoscopic Surgery Ann. Thorac. Surg., June 1, 2007; 83(6): 1978 - 1984. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |